Publikationen, an denen er mitarbeitet Julio López Abán (22)

2024

  1. Current drug strategies for the treatment and control of schistosomiasis

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 4, pp. 409-420

2022

  1. Diseño y elaboración de rúbricas para la autoevaluación y evaluación de las actividades

    I Jornada de Innovación Docente de las Universidades Públicas de Castilla y León

  2. Evaluation of the Immunomodulatory Effect of the Recombinant 14-3-3 and Major Antigen Proteins of Strongyloides stercoralis against an Infection by S. venezuelensis

    Vaccines, Vol. 10, Núm. 8

  3. Modelo in vitro para evaluar la actividad de compuestos antiparasitarios frente a Trichinella spiralis

    XII Congreso de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI)

2021

  1. T cell peptides derived from invasive stages of schistosoma mansoni as potential schistosomiasis vaccine

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-14

2019

  1. Diseño, síntesis y evaluación de amidas y sulfonamidas con actividad tipo colchicina contra Strongyloides venezuelensis

    XI Congreso de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI)

  2. Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis

    Frontiers in Immunology, Vol. 10

2018

  1. Electronic portfolio in a scientific methodology course at the Faculty of Pharmacyof the University of Salamanca

    IPAP 18 Innovations in Pharmacy: Advances and Perspectives

2017

  1. Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model

    BMC Infectious Diseases, Vol. 17, Núm. 1

2016

  1. Aza-polyheterocyclic compounds derived from antineoplastic and antiparasitic terpenylnapthquinones

    VIII Simpósio Iberoamericano de Plantas Medicinais (VIII SIPM) e III Simpósio Iberoamericano de Investigação em Câncer (III SIIC)

  2. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis

    Parasites and Vectors, Vol. 9, Núm. 1

  3. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems

    Parasites and Vectors, Vol. 9, Núm. 1

2015

  1. Actividad de aminoalcoholes y diaminas frente a Strongyloides venezuelensis

    XIX Congreso de la Sociedad Española de Parasitología (SOCEPA)

  2. The combination of the aliphatic diamine AA0029 in ADAD vaccination system with a recombinant fatty acid binding protein could be a good alternative for the animal schistosomiasis control

    Experimental Parasitology, Vol. 154, pp. 134-142

  3. Trypanocidal Activity of Long Chain Diamines and Aminoalcohols

    Molecules, Vol. 20, Núm. 6, pp. 11554-11568

2014

  1. In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes

    PLoS ONE, Vol. 9, Núm. 8

  2. Textos científicos elaborados por estudiantes de primer curso del Grado en Farmacia: cinco años de experiencia

    FECIES 2013: X Foro Internacional sobre Evaluación de la Calidad de la Investigación y de la Educación Superior

2012

  1. Adaptive immune stimulation is required to obtain high protection with fatty acid binding protein vaccine candidate against fasciola hepatica in balb/C mice

    Journal of Parasitology, Vol. 98, Núm. 3, pp. 527-535

2010

  1. Elaboración de textos científicos desde primer curso del grado: experiencia en la asignatura "Información y Metodología Científica"

    Ars pharmaceutica, Vol. 51, Núm. 1, pp. 425-434

  2. Vaccination against strongyloides venezuelensis with homologue antigens using new immunomodulators

    Journal of Parasitology, Vol. 96, Núm. 3, pp. 643-647